Home » Topics » BioWorld Science

BioWorld Science
RSS

ImmVira leverages viral vectors to enable CAR-T therapy for solid tumors

Jan. 25, 2022

KIN-3248 shows efficacy against tumors with clinically relevant FGFR mutations

Jan. 25, 2022

PL-8177 shows promise in preclinical models of induced colitis

Jan. 25, 2022

Qualigen to develop G4-selective transcription inhibitor from UCL for cancer

Jan. 25, 2022

CBD inhibits SARS-CoV-2 replication during early stages of infection in mice

Jan. 25, 2022

Shanghai Newsky Biotechnology identifies PLA2G7 inhibitors

Jan. 25, 2022

Medshine Discovery synthesizes new ER-alpha degradation inducers

Jan. 25, 2022

Wuhan LL Science and Technology Development divulges TRPC5 antagonists

Jan. 25, 2022

Chinese researchers patent new antibacterial compounds

Jan. 25, 2022

Suzhou Vintagence Pharma discloses new GTPase KRAS mutant inhibitors

Jan. 25, 2022

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...